TEE
XENT

Tibra Equities Europe’s Intersect ENT, Inc XENT Stock Holding History

Tibra Equities Europe’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$728K Buy
+26,000
New +$713K 0.81% 13
2019
Q2 		– Sell
-23,500
Closed -$756K – 487
2019
Q1 		$756K Buy
+23,500
New +$727K 0.08% 206

Other funds holding XENT

VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tibra Equities Europe's XENT Position: Q1 2022 in Review

Tibra Equities Europe opened a new position in Intersect ENT, Inc (XENT) in Q1 2022: 26,000 shares worth $728K. The stake represents 0.81% of the portfolio and ranks #13 among its holdings. This is a return to the name: Tibra Equities Europe previously reported a position in XENT as recently as Q1 2019.

Tibra Equities Europe first reported a position in XENT in Q1 2019 and has held it in 2 quarters since. The position peaked at $756K in Q1 2019. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Tibra Equities Europe held 26,000 shares of Intersect ENT, Inc worth $728K as of Q1 2022.
  • Intersect ENT, Inc was a new Tibra Equities Europe position in Q1 2022.
  • Intersect ENT, Inc made up 0.81% of Tibra Equities Europe's portfolio in Q1 2022, its #13 holding.
  • Tibra Equities Europe first reported a position in Intersect ENT, Inc in Q1 2019 and has held it in 2 quarters since.
  • Tibra Equities Europe's Intersect ENT, Inc position peaked at $756K in Q1 2019.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Tibra Equities Europe's 13F filing for Q1 2022, filed 16 May 2022.